_1777294007302_731105501.png&w=48&q=75){kind=small}
Study highlights risky use of weight loss meds
A new study has revealed that the use of obesity and diabetes medications known as GLP-1 receptor agonists has become common among individuals with eating disorders, raising concerns about misuse and their psychological and physical effects.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)